CA1045032A - Antihemophilic factor - Google Patents

Antihemophilic factor

Info

Publication number
CA1045032A
CA1045032A CA224,394A CA224394A CA1045032A CA 1045032 A CA1045032 A CA 1045032A CA 224394 A CA224394 A CA 224394A CA 1045032 A CA1045032 A CA 1045032A
Authority
CA
Canada
Prior art keywords
extract
temperature
buffer
minutes
cryoprecipitate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA224,394A
Other languages
English (en)
French (fr)
Other versions
CA224394S (en
Inventor
James J. Hagan
Charles Glaser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Application granted granted Critical
Publication of CA1045032A publication Critical patent/CA1045032A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA224,394A 1974-04-12 1975-04-11 Antihemophilic factor Expired CA1045032A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US46041774A 1974-04-12 1974-04-12

Publications (1)

Publication Number Publication Date
CA1045032A true CA1045032A (en) 1978-12-26

Family

ID=23828619

Family Applications (1)

Application Number Title Priority Date Filing Date
CA224,394A Expired CA1045032A (en) 1974-04-12 1975-04-11 Antihemophilic factor

Country Status (5)

Country Link
JP (1) JPS50142719A (en)van)
CA (1) CA1045032A (en)van)
DE (1) DE2516186A1 (en)van)
FR (1) FR2267113B1 (en)van)
GB (1) GB1507198A (en)van)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2624373C2 (de) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
CA1054052A (en) * 1976-08-14 1979-05-08 Edward Shanbrom Simplified method for preparation of high yield, high purity factor viii concentrate
US4302445A (en) * 1980-01-18 1981-11-24 Institut Merieux Method for concentrating and purifying antihemophilic factor or factor VIII
JPS5867627A (ja) * 1981-10-12 1983-04-22 ア−マ−・フア−マシユ−テイカル・カンパニ− 高純度抗血友病性因子の製造法
DE3318521A1 (de) * 1983-05-20 1984-11-22 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Verfahren zur herstellung eines antihaemophiliefaktor-konzentrats
CA1293941C (en) * 1985-11-08 1992-01-07 Maria Erlinda Co-Sarno Method for preparing antihemophilic factor (ahf) by cold precipitation and for improving solubility of recovered ahf product

Also Published As

Publication number Publication date
DE2516186A1 (de) 1975-10-30
FR2267113B1 (en)van) 1979-08-24
JPS50142719A (en)van) 1975-11-17
GB1507198A (en) 1978-04-12
FR2267113A1 (en)van) 1975-11-07

Similar Documents

Publication Publication Date Title
US3973002A (en) Antihemophilic factor
US4188318A (en) Simplified method for preparation of high yield, high purity Factor VIII concentrate
EP0047216B1 (en) Method of selectively increasing yield and purity of certain cryoprecipitate proteins
US4960757A (en) Pasteurized human fibrinogen (HF), a process for its preparation, and its use
US4251437A (en) Process for producing an antihemophilic factor preparation from human blood plasma by irradiating with electromagnetic waves
NO142381B (no) Fremgangsmaate for fremstilling av den antihemofile faktor
CA2086087C (en) Growth hormone crystals and a process for production of these gh-crystals
US4104266A (en) Method for preparation of antihemophilic factor
US2765299A (en) Recovery of serum albumin
CA1045032A (en) Antihemophilic factor
US4029655A (en) Method of preparing stable sterile crystalline cephalosporins for parenteral administration
GB1473548A (en) Bovine immunoglobulin isolation process
DK163107B (da) Fremgangsmaade til fremstilling af et koncentrat af antihaemofilisk faktor med hoej renhed
NO138145B (no) Fremgangsmaate for fremstilling av et enzympreparat
US2808362A (en) Preparation of hyaluronidase
GB1274940A (en) Isolation of proteins
US4285933A (en) Process for concentrating blood coagulation Factor XIII derived from human placentae
JPS5910645B2 (ja) 第８因子の濃縮・精製方法
US2867567A (en) Process of preparing anti-haemophilic globulin
US4294826A (en) Process for the preparation of highly purified antihemophilic factor
US3627642A (en) Lysozyme salts
FI84136C (fi) Foerfarande foer framstaellning av gamma-globulin vilket laempar sig foer intravenoest administration.
US3382227A (en) Blood protein fractionation employing 2-ethoxy-6, 9-diamino-acridine-lactate
US3664926A (en) Crystallization of l-asparaginase
US8389687B2 (en) Polyvinylpyrrolidone cryoprecipitate extraction of clotting factors